Frailty and pre-frailty phenotypes increase the odds of abnormal cognitive impairment screens in people living with HIV
dc.rights.license | open | en_US |
dc.contributor.author | MAKINSON, Alain | |
dc.contributor.author | ALLAVENA, Clotilde | |
hal.structure.identifier | Centre de recherche en épidémiologie et santé des populations [CESP] | |
dc.contributor.author | ABULIZI, Xian | |
dc.contributor.author | SLAMA, Laurence | |
hal.structure.identifier | Centre de recherche en épidémiologie et santé des populations [CESP] | |
dc.contributor.author | CASES, Antoine | |
dc.contributor.author | TROUILLET, Marion Bourgey | |
dc.contributor.author | BLONDEL, Guillaume Martin | |
dc.contributor.author | GENY, Christian | |
dc.contributor.author | LECLERCQ, Pascale | |
hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
dc.contributor.author | CAZANAVE, Charles | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | BONNET, Fabrice | |
dc.contributor.author | NAQVI, Alissa | |
dc.contributor.author | DAVID-CHEVALLIER, Perla | |
dc.contributor.author | ARVIEUX, Cédric | |
dc.contributor.author | KATLAMA, Christine | |
hal.structure.identifier | Pathogenesis and Control of Chronic and Emerging Infections [PCCEI] | |
dc.contributor.author | CABIE, André | |
hal.structure.identifier | Centre de recherche en épidémiologie et santé des populations [CESP] | |
dc.contributor.author | ANDRIANTSOANIRINA, Valérie | |
dc.contributor.author | BLAIN, Hubert | |
hal.structure.identifier | Centre de recherche en épidémiologie et santé des populations [CESP] | |
dc.contributor.author | MEYER, Laurence | |
dc.date.accessioned | 2025-01-14T07:55:08Z | |
dc.date.available | 2025-01-14T07:55:08Z | |
dc.date.issued | 2023-08-03 | |
dc.identifier.issn | 0269-9370 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/204249 | |
dc.description.abstractEn | Objective: Evaluate whether pre-frail and frail PLWH have a higher risk of cognitive impairment on screens. Methods: Analysis of PLWH aged 70 or older included in the ANRS EP66 SEPTAVIH cohort, on antiretroviral therapy for at least 12 months and with a MoCA test at enrolment. Adjusted risk of a Montreal Cognitive Assessment (MoCA) 30.2), and 41.3% were college graduates; 27.3% had a history of clinical AIDS. 294 (58.5%) PLWH had a MoCA score <26; 182 (36%) a MoCA score ≤ 23. Frailty, pre-frailty, and robustness were found in 13.1%, 63.6% and 23.3% participants, respectively. PLWH with a MoCA < 26 had a significantly higher risk of being frail/prefrail, this before (OR = 2.31 [95% CI: 1.50, 3.57]), and after adjustment for confounders (OR = 1.80, [1.07–3.01]). The risk of being frail/prefrail in patients with a MoCA ≤ 23 was higher (adjusted OR = 2.75, [95%CI: 1.46–5.16]). Other factors independently associated with a MoCA < 26 were older age, birth outside of France, and a lower education level and being diabetic. Conclusions: Abnormal MoCA screens were frequent in our cohort of PLWH aged 70 or older with controlled HIV disease. Cognitive impairment should be systematically screened in frail/prefrail PLWH. Frailty/pre-frailty, diabetes and social factors, but not HIV-related factors, are important determinants of cognitive function in PLWH with controlled disease. | |
dc.language.iso | EN | en_US |
dc.title.en | Frailty and pre-frailty phenotypes increase the odds of abnormal cognitive impairment screens in people living with HIV | |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1097/QAD.0000000000003681 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio] | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Immunologie | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Médecine humaine et pathologie | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Maladies infectieuses | en_US |
dc.identifier.pubmed | 37534690 | en_US |
bordeaux.journal | AIDS. Official journal of the international AIDS Society | en_US |
bordeaux.hal.laboratories | MFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234 | en_US |
bordeaux.institution | CNRS | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.import.source | hal | |
hal.identifier | hal-04240927 | |
hal.version | 1 | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | false | |
workflow.import.source | hal | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=AIDS.%20Official%20journal%20of%20the%20international%20AIDS%20Society&rft.date=2023-08-03&rft.eissn=0269-9370&rft.issn=0269-9370&rft.au=MAKINSON,%20Alain&ALLAVENA,%20Clotilde&ABULIZI,%20Xian&SLAMA,%20Laurence&CASES,%20Antoine&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |